News

The double-blind study demonstrated considerable boost in the intestinal flora of the infants such as Lactobacilli and Bifidobacteria, when fed with InFat. Multicenter study designed to assess the

Developed by MyoRX, the topical solution cream leverages the lipophilic properties of omega-3 fatty acids in combination with aspirin to create a medical delivery mechanism with minimal side

UMEC/VI is a combination of two investigational bronchodilator molecules, GSK573719 or UMEC, a long-acting muscarinic antagonist (LAMA) and vilanterol, a long-acting beta2 agonist (LABA), administered using the ELLIPTA

Upon closing the sale, the non-Colcrys assets of URL Pharma will be owned and managed by Caraco. The deal is subject to customary closing conditions as well as

As part of the collaboration, Lorus will test the anticancer activity and drug-like properties of pancratistatin derivatives synthesized by Dr. Tomas Hudlicky”s research group at Brock University. Lorus

The multi-centre, randomised study will evaluate the efficacy and safety of two different doses of Nefecon, an enteric formulation of a locally acting corticosteroid. Primary objective of the

Under the agreement, WuXi will provide JV with clinical and regulatory services from its China-based clinical organization as well as supply laboratory services through a preferred provider arrangement.

The patent entitled ‘ Polymer Microspheres/Nanospheres and Encapsulating Therapeutic Proteins Therein’ covers the company’s oral delivery nanotechnology, designed for improving the oral bioavailability of macromolecules like insulin. Aphios

The FDA approved, once-daily, oral product is indicated for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Linzess was designed to act locally